These findings suggest that therapeutic strategies targeting c-Abl inhibition, modulation of α-Syn phosphorylation, and restoration of autophagy could offer promising avenues for controlling PD and attenuating its progression. The gene discussed is ABL1; the disease is Parkinson disease.